International Journal of Drug Delivery Technology
Volume 16, Issue 7s, 2026

Evaluation of Tuberculosis Control Innovation Programs at Community Health Centers (Puskesmas) in Cirebon City, Indonesia

Kartono 1,5*, Indah Gilang Pusparani 2, Kurnia Tri Hermawan 3, Novid Gumelar 4, Ratna Andika 5

1,5*Swadaya Gunung Jati University, Cirebon City, West Java, Indonesia.
Email: kartono@ugj.ac.id (Corresponding Author)

2Regional Development Planning and Research Agency, Cirebon City, West Java, Indonesia.
Email: indahgilang@gmail.com

3Regional Development Planning and Research Agency, Cirebon City, West Java, Indonesia.
Email: trihermawan.research@gmail.com

4Regional Development Planning and Research Agency, Cirebon City, West Java, Indonesia.
Email: novidgum@gmail.com

5Swadaya Gunung Jati University, Cirebon City, West Java, Indonesia.

*Corresponding Author: Kartono, Swadaya Gunung Jati University, Cirebon City, West Java, Indonesia. Email: kartono@ugj.ac.id


ABSTRACT

Background: Tuberculosis (TB) control is one of Indonesia's national development priorities because Indonesia has the second highest TB burden globally. In 2021, Cirebon City had the second-highest number of TB patients in West Java province, while West Java had the highest number of TB patients in Indonesia. One of the national TB eradication strategies was TB control innovation.

Aims: This study aimed to evaluate regional innovation programs for TB control across all community health centers (Puskesmas) in Cirebon City.

Methods: This study employed a mixed-methods approach with concurrent model triangulation, combining qualitative and quantitative research methods. The study subjects were 22 Puskesmas in Cirebon City, TB patients, and the Cirebon City Health Agency. Data collection techniques included a literature review, in-depth interviews, focus group discussions (FGDs), questionnaires, field research, and observation. The qualitative method of this study was a post-intervention project group. The quantitative stage used a before-and-after data comparison to measure the impact of the innovation program. Data analysis was conducted by combining qualitative and quantitative sources, including FGD interviews, program data, and Puskesmas statistical data. Impact was measured by comparing input, process, and output indicators using data before and after the innovation was implemented.

Conclusion: This study concluded that after the implementation of TB control innovation programs in Puskesmas, TB case detection and the number of TB suspects treated increased. Program innovation for tuberculosis (TB) control must be continuously sustained and further developed to accelerate progress toward achieving the targeted reduction in TB burden.

Keywords: Innovation impact, regional innovation, program evaluation, public service delivery, tuberculosis control.

How to cite this article: Kartono, Pusparani IG, Hermawan KT, Gumelar N, Andika R. Evaluation of tuberculosis control innovation programs at community health centers (Puskesmas) in Cirebon City, Indonesia. Int J Drug Deliv Technol. 2026;16(7s): 92-108; DOI: 10.25258/ijddt.16.7s.13

Source of support: Nil.

Conflict of interest: None